Share Name Share Symbol Market Type Share ISIN Share Description
Cenkos Securities Plc LSE:CNKS London Ordinary Share GB00B1FLHR07 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 62.00 3,311 08:00:00
Bid Price Offer Price High Price Low Price Open Price
60.00 64.00 62.00 62.00 62.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 37.23 3.95 7.10 8.7 35
Last Trade Time Trade Type Trade Size Trade Price Currency
12:15:30 O 1,603 62.35 GBX

Cenkos Securities (CNKS) Latest News

More Cenkos Securities News
Cenkos Securities Investors    Cenkos Securities Takeover Rumours

Cenkos Securities (CNKS) Discussions and Chat

Cenkos Securities Forums and Chat

Date Time Title Posts
23/6/202213:47Cenkos - Racing to the top?3,994
11/7/201614:04*** Cenkos Securities ***3
31/3/201513:18CNKS Cenkos228
23/11/201408:31$CNKS.L – investing is never easy-
04/7/201111:59Cenkos Securities7

Add a New Thread

Cenkos Securities (CNKS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:15:3162.351,603999.47O
08:40:3062.351,6711,041.87O
08:18:5362.353723.07O
View all Cenkos Securities trades in real-time

Cenkos Securities (CNKS) Top Chat Posts

DateSubject
07/7/2022
09:20
Cenkos Securities Daily Update: Cenkos Securities Plc is listed in the General Financial sector of the London Stock Exchange with ticker CNKS. The last closing price for Cenkos Securities was 62p.
Cenkos Securities Plc has a 4 week average price of 62p and a 12 week average price of 62p.
The 1 year high share price is 92p while the 1 year low share price is currently 52.50p.
There are currently 56,694,783 shares in issue and the average daily traded volume is 246,346 shares. The market capitalisation of Cenkos Securities Plc is £35,150,765.46.
10/6/2022
08:26
quepassa: It remains to be seen what will happen to the major/largest shareholder stake of 9.66% held in the estate of Andrew Stewart (deceased 13/9/21). Cannacord Genuity are the next largest significant holder at 9.2% and J Durkin at 8.2%. That 9.66% stake is worth roughly £3.5 million at today's price. ALL IMO. DYOR. QP
25/5/2022
09:01
speedsgh: Cenkos scores five hires to bolster growth - HTTPS://www.fnlondon.com/articles/cenkos-scores-five-hires-to-bolster-growth-20220524 Institutional stockbroker Cenkos has scored five new hires as it looks to grow its corporate finance, sales and research teams. Former head of corporate finance at WH Ireland, Adrian Hadden, will join Cenkos as director in the corporate finance team, and is set to add private fundraisings to his focus. In addition to roles at other City firms, Hadden was also previously a director at Collins Stewart Hawkpoint. Also joining from WH Ireland is former managing director Jasper Berry, who joins Cenkos’ growth companies sales team as a director. Berry has “a wealth of experience”, Cenkos says, on account of previous experience at Collins Stewart, Société Générale Investment Management and NatWest Stockbrokers. Cenkos has made more than 20 hires over the past 18 months in an effort to build out its presence in both the growth and investment company sectors. The firm raised more than £1.2bn for clients last year and kicked off 2022 with three IPOs, four placings and two M&A transactions in the first three months. The growth comes under new boss Julian Morse, who took over from Jim Durkin after a volatile period. Under Morse’s early leadership, the firm saw expansion and a rebound in the company’s fortunes, with revenues surging by 37% to £18.2m for the first half of 2021, while profits were up by 40% to £2.8m, Financial News previously reported. The new hires also include chartered accountant Charlie Combe, who joins the growth team. Combe was previously global sales director at Edison and prior to that, a corporate financier at Smith & Williamson. Cenkos is also boosting its research capability with the appointment of Andrew Gibb to focus on business and financial services. Gibb has some 20 years’ experience covering various sectors at a number of firms including Investec, RBC, Singer, and Arden Partners. Edward Stacey also joins the firm’s property and industrials unit, having spent more than two decades analysing companies for firms including HSBC, SocGen and Proactive Investors. “The recruitment of experienced operators in the growth companies market, with their wealth of knowledge, expertise and relationships, will help us continue to build Cenkos’ franchise and market share. We see lots of opportunity in the UK equities market and are in an excellent position to make the most of them,” Morse said.
23/5/2022
08:43
quepassa: Cenkos goes XD this Thursday 26th for 3p. Pays 23rd. June. Based on this morning's mid-price of 67p, Cenkos now yields a highly attractive 6.34%. ALL IMO. DYOR. QP
12/5/2022
09:21
speedsgh: AGM Statement (11/5) - HTTPS://www.investegate.co.uk/cenkos-securities--cnks-/rns/agm-statement/202205110700030158L/ "The Company had a good start to the year having completed three IPOs, four placings and two M&A transactions within the first 10 weeks of the year. Since the announcement of our 2021 results issued in mid-March 2022, the macro-environment has remained challenging with the continuing war in Ukraine combined with mounting inflation and interest rate concerns in turn impacting investor risk appetite and capital markets activity generally. Despite this we remain confident in our business model and our track record of successful fundraising at every stage of the market cycle and continue to maintain our strong balance sheet and financial resources well in excess of regulatory requirements. We are currently working on a number of transactions for our clients and have an encouraging pipeline for the rest of the year."
31/3/2022
09:14
nigelmoat: As a long term holder here can remember the days when this share traded north of 200 pence. With a new quality team at the helm hoping for good times ahead. Added to my position yesterday.
30/3/2022
15:07
quepassa: An excellent piece of research has been released today by Edison Group on Cenkos and the recent year-end results. hXXps://www.edisongroup.com/publication/uncertain-background-but-resilient-model/30682/ Some highlights in the Note show: -Tremendous growth in EPS to 6p compared with EPS of 3.3p, 0.1p, 4.4p in prior years 20/19/18 -P/E now on 13.4x compared to 24.5x in previous year -Dividend increased overall by 21% - Cash at £33.5 million. -Valuation. Cenkos now trades on a price-to-book value of c. 1.4x compared to 10 year average of 2.1x - Regulatory capital SURPLUS of £15.8million - Significant increase in revenue per capita to £410k ( £350k) -Client increase by 8% to 101 clients See Edison's Note for full details and context. This share remains -in my view- very cheap on fundamentals, yield, earnings growth, sector comparisons and has buoyant prospects and outlook under new management with an evolving corporate strategy including a welcome "shift to quality". ALL IMO. DYOR. QP
18/3/2022
07:29
quepassa: Strong results:- -The Profit after Tax has gone up by a massive 75% from from £2.3m to £4m -Cash balances even stronger at c £34.5m -Increased final divi by 20% from 2.5p to 3p. -Overall annual dividend increased by 21% from 3.5p to 4.25p. Share now yielding a very attractive 7.1% ( 4.25p on share price of 60p) against a buoyant outlook, a noteable increase in new hires/dealmakers together with the welcome impementation of a strategic "shift to quality". Looking good. Great maiden results for the new CEO. Well done to Cenkos. ALL IMO. DYOR. QP
02/7/2021
18:46
rainmaker: Re technical analysis, IMHO fundamentals are the absolute king, no question. I believe Cenkos corporate finance department that deals with IPOs, the bulk of the business and the main profit driver at approx 75% of turnover, has a very bright future and as I expected, we have struck a trade deal with the EU(with a large trade surplus with the UK, they couldn't afford not to)and Covid 19 virus is now under control so I'm confident about Cenkos prospects. I know technical analysis inside out, as I have been using it for a number of years and I will use it when appropriate and relevant as I find it useful for timing trades and spotting confirmation of opportunities that the Market will miss. For example I have numerous holdings in Hong Kong stock exchange listed business where for several reasons, I expected a substantial rise in the share price. The share price of this Company was trading at historically very low levels, bumping along the bottom with little interest and small daily volume then one day, it broke into new low ground but then rallied to close above the previous day's high-what technicians refer to as a key or acute reversal, a powerful technical indicator that a sudden trend reversal is imminent and it did it on, and was validated by, so called "explosive" volume, 4 times the three month daily average and I immediately starting buying and within a few days or so, the share price had doubled and a month to six weeks it had gone up three fold........ regards
26/1/2021
10:29
kenmitch: That’s good news. A few more, and decent dividend increase and considerable share price gain looking ever more likely. Let’s hope they get an increasing amount of new business. So much of the share price is still cash so it won’t take much for share price to rocket and perhaps a “results likely to be better (or better still significantly better) than expected” trading update to trigger the share price rise quite soon. Better to be in ahead of that than possibly chasing the share price after it?
05/3/2019
10:10
speedsgh: Hi QP. I am not qualified to make a qualitative comparison between WHI & CNKS. However the CNKS TU of 19/12 was backward-looking (and I am guessing largely as a result of the fees earned on the ESUR takeover which completed in Dec) whereas the WHI statement today is forward-looking so of potential relevance to all sector peers. AFAICT CNKS have been involved in just 2 fundraisings in Jan/Feb 2019: a £1.15m subscription for Personal Group (PGH) & a £21m placing/open offer for Kromek Group (KMK). Whilst 2 months does not make a year, it is interesting to compare Jan/Feb performance to recent years (based on fundraisings announced): Jan/Feb 2016: £270m Jan/Feb 2017: £163m Jan/Feb 2018: £54m Jan/Feb 2019: £22.15m Numis AGM Update on 5/2/19: "Since the start of the financial year [on 1/10/2018], UK equity indices have suffered material declines and the domestic political situation has significantly impacted investor sentiment in the UK. As a result the market backdrop has been particularly challenging for our corporate and institutional clients, which has ultimately impacted our trading performance in the first four months of the year... ... We have a good pipeline of opportunities, and would expect to see a meaningful increase in revenue, as and when there is greater clarity regarding the UK macro-economic and political landscape." All this would suggest that times are tough for the sector. AFAICS possible short-term drivers of CNKs share price: > Corporate action > Removal of Brexit uncertainty allowing UK plc to start investing again which would be beneficial for the sector AIMHO
Cenkos Securities share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CNKS
Cenkos Sec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220707 13:15:55